Chrysos Corp Ltd
ASX:C79
Chrysos Corp Ltd
Chrysos Corp Ltd is a AU-based company operating in Commercial Services & Supplies industry. The company is headquartered in Adelaide, South Australia. The company went IPO on 2022-05-06. Chrysos Corporation Limited is an Australia-based company, which provides gold testing technology. The firm is focused to combine science and software to create technology solutions for the global mining industry. The firm's flagship product, PhotonAssay provides quantitative data to all the mining exploration companies. PhotonAssay is an environmentally friendly replacement for fire assay on-site and in the laboratory. Its technology causes excitation of atomic nuclei allowing enhanced analysis of gold, silver, copper and other elements. The firm operates in Australia, North America and Africa.
Chrysos Corp Ltd is a AU-based company operating in Commercial Services & Supplies industry. The company is headquartered in Adelaide, South Australia. The company went IPO on 2022-05-06. Chrysos Corporation Limited is an Australia-based company, which provides gold testing technology. The firm is focused to combine science and software to create technology solutions for the global mining industry. The firm's flagship product, PhotonAssay provides quantitative data to all the mining exploration companies. PhotonAssay is an environmentally friendly replacement for fire assay on-site and in the laboratory. Its technology causes excitation of atomic nuclei allowing enhanced analysis of gold, silver, copper and other elements. The firm operates in Australia, North America and Africa.
Revenue Growth: Chrysos reported revenue of $15.3 million, up 53% year-on-year and 12% quarter-on-quarter, with significant growth outside Australia, especially in the Americas (up 305% YoY) and EMEA (up 42% YoY).
Record Sample Volumes: The company achieved its 25th consecutive quarter of record PhotonAssay sample volumes, up 53% year-on-year, indicating ongoing strong demand.
Strong Balance Sheet: Chrysos ended the quarter with $26.6 million in cash and an undrawn $95 million green loan, providing over $120 million available for growth investments.
Deployment Progress: 34 PhotonAssay units are now operating globally, after 3 new deployments this quarter. The total number of contracted units rose to 56.
Guidance Reaffirmed: Management confirmed FY '25 revenue guidance of $60–70 million and EBITDA guidance of $9–10 million.
Business Model Shift: The company continues shifting to direct contracts with miners, supported by an expanded sales team, while also maintaining strong relationships with major labs.
Cost Structure: Operating costs are becoming increasingly incremental, with most major team expansions now complete, supporting ongoing EBITDA improvement.
